RESI Conference at MaRS Discovery District - June 23

May 31, 2016

Life Science Nation (LSN) and MaRS Discovery District (MaRS) are collaborating with Johnson & Johnson Innovation, JLABS to bring the Redefining Early Stage Investments (RESI) Conference to Toronto on June 23, 2016.

The RESI Conference series brings together fundraising CEOs and early stage investors from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations.

“MaRS supports over 250 Canadian-grown early stage health technology startups,” said Dr. Zayna Khayat, Lead, MaRS Health. “Our goal is to provide these young emerging ventures with the best connections to investors and industry to help them scale internationally. The Redefining Early Stage Investments (RESI) conference series has a strong track record of attracting global early stage investors. We’re delighted to bring them to MaRS in 2016 to build on the success of our HealthKick conferences and support new technologies that will achieve better health outcomes.”

Johnson & Johnson Innovation, JLABS, MaRS, the Ontario Government, University of Toronto and other collaborators announced last week that JLABS will be opening its first ex-U.S. incubator in Toronto. Called JLABS @ Toronto, the site is expected to open in the Spring of 2016. JLABS @ Toronto, MaRS and RESI will connect cutting-edge health technologies with a broad audience of investors and industry leaders including: angel syndicates, family offices/private wealth firms, corporate venture capitalists, venture philanthropy groups, foundations and endowments, pharmaceutical companies, mid-level private equity firms, government organizations, and venture capital investors.

“The MaRS Centre in Toronto represents the 4th venue for our North American RESI Conference series. Now fundraising CEOs and scientist entrepreneurs can meet investors every 90 days – Boston in September (RESI Boston), San Francisco in January (RESI @ JPM), Houston in April (RESI @ TMCx) and now Toronto in June (RESI on MaRS),” said Dennis Ford, CEO of LSN and creator of the RESI Conference Series. “Fundraising is essentially a numbers game and the entrepreneur needs to get in front of as many investors as possible. Having as many as 20 investor meetings every 90 days can dramatically help with funding in the healthcare arena.”

To register, click here

For more information, visit

Source: Life Science Nation

For more information,